Selective delivery of rifampicin incorporated into poly(dl-lactic-co-glycolic) acid microspheres after phagocytotic uptake by alveolar macrophages, and the killing effect against intracellular Mycobacterium bovis Calmette–Guérin
- 31 August 2006
- journal article
- research article
- Published by Elsevier BV in Microbes and Infection
- Vol. 8 (9-10), 2484-2491
- https://doi.org/10.1016/j.micinf.2006.06.004
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Agriculture, Forestry and Fisheries
This publication has 10 references indexed in Scilit:
- Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicinColloids and Surfaces B: Biointerfaces, 2004
- Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosisInternational Journal of Antimicrobial Agents, 2004
- Chemotherapeutic Potential of Orally Administered Poly(Lactide-Co-Glycolide) Microparticles Containing Isoniazid, Rifampin, and Pyrazinamide against Experimental TuberculosisAntimicrobial Agents and Chemotherapy, 2003
- Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomesInternational Journal of Antimicrobial Agents, 2002
- Residual polyvinyl alcohol associated with poly (d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptakeJournal of Controlled Release, 2002
- Mycobacterium tuberculosis: here today, and here tomorrowNature Reviews Molecular Cell Biology, 2001
- Treatment of Tuberculosis Using a Combination of Sustained-Release Rifampin-Loaded Microspheres and Oral Dosing with IsoniazidAntimicrobial Agents and Chemotherapy, 2001
- Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model.Pharmaceutical Research, 2001
- Inhalable Microparticles Containing Drug Combinations to Target Alveolar Macrophages for Treatment of Pulmonary TuberculosisPharmaceutical Research, 2001
- Use of Microsphere Technology for Targeted Delivery of Rifampin to Mycobacterium tuberculosis -Infected MacrophagesAntimicrobial Agents and Chemotherapy, 1998